OQROGet OQRO Pro
Insider trade

Cartesian Therapeutics (RNAC)Chief Medical Officer sold ~$343K

Milos Miljkovic, Chief Medical Officer at Cartesian Therapeutics, sold ~$343K of Cartesian Therapeutics shares.

~$343K
Approx. value · 20K sh @ $17.14
18K
Holds after · shares reported
Traded
Nov 15, 2024
Filed
Nov 19, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 2, 2024InsiderDirector purchased ~$96K of RNAC shares in the open market
  2. Oct 3, 2024Insider · 1 personInsiders: 5 purchases (~$2.4M)
  3. Oct 4, 2024Insider · 1 personInsiders: 4 purchases (~$1.8M)
  4. Nov 14, 2024Insider · 4 peopleInsiders: 2 purchases (~$1.6M), 5 sales (~$1.6M)
  5. Nov 15, 2024 · this disclosureInsiderOfficer sold ~$343K of RNAC shares in the open market

What came next

  1. Nov 15, 2024Insider · 3 peopleInsiders: 1 purchase (~$4.7M), 2 sales (~$654K)
  2. Nov 18, 2024Insider · 2 peopleInsiders: 2 purchases (~$1.1M), 2 sales (~$633K)
  3. Nov 19, 2024InsiderOfficer sold ~$3.9K of RNAC shares in the open market
  4. Nov 20, 2024Insider · 1 personInsiders: 2 sales (~$99K)
  5. Nov 21, 2024InsiderOfficer sold ~$547K of RNAC shares in the open market
  6. Dec 9, 2024Insider · 1 personInsiders: 2 sales (~$274K)
  7. Dec 10, 2024InsiderOfficer sold ~$71K of RNAC shares in the open market
  8. Dec 19, 2024Insider · 1 personInsiders: 3 purchases (~$454K)
  9. Dec 20, 2024InsiderDirector purchased ~$413K of RNAC shares in the open market
  10. Dec 23, 2024InsiderDirector purchased ~$98K of RNAC shares in the open market
  11. Jan 3, 2025Insider · 6 peopleInsiders: 6 sales (~$301K)
  12. Jan 6, 2025Insider · 6 peopleInsiders: 6 sales (~$309K)
  13. Jan 13, 2025Insider · 1 personInsiders: 2 purchases (~$294K)
  14. Jan 14, 2025InsiderDirector purchased ~$72K of RNAC shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Cartesian Therapeutics

OQRO holds no insider, Congress, fund or contract record for Cartesian Therapeutics dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its RNAC page.

Other recent filings by Milos Miljkovic, Chief Medical Officer

The full history of Milos Miljkovic, Chief Medical Officer is on the profile page.

How this filing works

Other disclosures at Cartesian Therapeutics

Everything OQRO holds on this company is on its RNAC page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data